Zomedica Corp. (ZOMDF)

OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0140 (38.89%)
Mar 14, 2025, 4:00 PM EST
-64.03%
Market Cap 49.05M
Revenue (ttm) 27.29M
Net Income (ttm) -46.98M
Shares Out 979.95M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,162,800
Average Volume 13,814,343
Open 0.0390
Previous Close 0.0360
Day's Range 0.0380 - 0.0520
52-Week Range 0.0150 - 0.1950
Beta 1.16
RSI 30.24
Earnings Date Mar 13, 2025

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line... [Read more]

Industry Medical Devices
Sector Healthcare
CEO Larry Heaton
Employees 144
Stock Exchange OTCMKTS
Ticker Symbol ZOMDF
Full Company Profile

Financial Performance

In 2024, Zomedica's revenue was $27.29 million, an increase of 8.33% compared to the previous year's $25.19 million. Losses were -$46.98 million, 36.1% more than in 2023.

Financial Statements

News

Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript

Zomedica Corp. (OTC:ZOMDF) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Company Participants Mike Vallie – ICR Larry Heaton – Chief Executive Officer Scott Jordan – Executive Vice Presid...

3 days ago - Seeking Alpha

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth

ANN ARBOR, MI / ACCESS Newswire / March 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products fo...

3 days ago - Accesswire

Zomedica Corp. Announces Transition to OTCQB Venture Market

Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company of...

12 days ago - Accesswire

NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of...

12 days ago - Business Wire

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic pr...

18 days ago - Accesswire

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters

Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica...

4 weeks ago - Accesswire

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM...

5 weeks ago - Accesswire

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market

License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"),...

2 months ago - Accesswire

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone

With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomed...

2 months ago - Accesswire

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinar...

3 months ago - Accesswire

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024

ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic produc...

3 months ago - Accesswire

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zo...

4 months ago - Accesswire

Noble Capital Markets Initiates Equity Research Coverage on Zomedica

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion an...

4 months ago - Accesswire

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024

ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic product...

4 months ago - Accesswire

Zomedica Corp. (ZOM) Q3 2024 Earnings Call Transcript

Zomedica Corp. (NYSE:ZOM) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Larry Heaton – Chief Executive Officer Mike Zuehlke – Vice President and Corporate Controll...

4 months ago - Seeking Alpha

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth

ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...

4 months ago - Accesswire

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform

New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure ANN ARBOR, MI / ACCESSWIRE / October 24, 2024 / Zomedica Cor...

5 months ago - Accesswire

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...

5 months ago - Accesswire

Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference

Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference ANN ARBOR, MI / ACCESSWIRE / October 15, 2024 / Zomedica Co...

5 months ago - Accesswire

Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe ANN ARBOR, MI / ACCESSWIRE / October 3, 2024 / Zomedica C...

5 months ago - Accesswire

Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota

Expanded cleanroom and improved distribution facilities enhance manufacturing capacity and shipping efficiencies ANN ARBOR, MI / ACCESSWIRE / September 11, 2024 / Zomedica Corp. (NYSE American:ZOM) ("...

6 months ago - Accesswire

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

CE Mark approval opens European market for TRUVIEW system ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company...

6 months ago - Accesswire

Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product

Assisi's tPEMF™ technology aligns with Fear Free's mission to “prevent and alleviate fear, anxiety, and stress in pets” ANN ARBOR, MI / ACCESSWIRE / August 29, 2024 / Zomedica Corp. (NYSE American:ZOM...

7 months ago - Accesswire

Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System

Increased functionality makes the VETGuardian system a must have for veterinarians ANN ARBOR, MI / ACCESSWIRE / August 22, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company", a vet...

7 months ago - Accesswire

More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively Buying

The Dow Jones index closed lower by more than 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

7 months ago - Benzinga